Medindia

X

GSK Type 1 Diabetes Drug Does Not Make It in Phase III Clinical Trials

by Savitha C Muppala on  March 13, 2011 at 2:37 PM Clinical Trials News   - G J E 4
A Type 1 diabetes drug developed by London-based GlaxoSmithKline and Cambridge, Massachusetts-based Tolerx, was not successful in the phase III clinical trials.
 GSK Type 1 Diabetes Drug Does Not Make It in Phase III Clinical Trials
GSK Type 1 Diabetes Drug Does Not Make It in Phase III Clinical Trials
Advertisement

Explaining their commitment to the clinical development of type 1 diabetes drug, Jackie Parkin, GSK's medicines development leader, said, "Clearly these are disappointing data, but we are committed to working with Tolerx to better understand the results of this study and determine the way forward."

Advertisement


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All